SLC35A2 and epilepsy: However, due to the weakened expression of UGT gene in children with epilepsy, the clinical treatment of drug therapy for children cannot be completely dependent on genetype testing but in combination with closely monitoring the drug plasma concentration to ensure that the individualized dosages are reasonably formulated to avoid adverse reactions.